Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ADAPALENE USP, with a corresponding US DMF Number 18756.
Remarkably, this DMF maintains an Active status since its submission on September 12, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2013, and payment made on November 26, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II